Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Open access
Collections
- IFF - Artigos de Periódicos [1300]
Metadata
Show full item record
A ASMA E A DPOC NA VISÃO DO PNEUMOLOGISTA
Asthma
Pulmonary Disease
Chronic Obstructive
Physician’s Practice Patterns
Brazil
Alternative title
Asthma and COPD according to the pulmonologistAuthor
Affilliation
Abstract in Portuguese
Objetivo:Avaliar como o pneumologista vê o impacto da asma e da DPOC na sua clientela, e como ele vem tratando
essas doenças. Métodos:Inquérito com 227 pneumologistas participantes do VI Congresso de Asma e II Congressos
Brasileiros de DPOC e de Tabagismo, realizados em 2007. Resultados:As respostas dos pneumologistas mostraram
que a DPOC é um problema de saúde pública igual ou maior que a asma, e que a DPOC causa inúmeros transtornos
para o doente e para seus familiares. Na escolha do dispositivo inalatório, a simplicidade de uso é mais importante
que o custo, havendo discreta predileção pelos sistemas Aeroliser
®
e Diskus
®
. A associação entre budesonida e formo-terol foi a conduta terapêutica mais citada para o tratamento continuado do asmático sintomático, enquanto o
brometo de tiotrópio foi o medicamento preferido pela maior parte para o tratamento continuado do portador de
DPOC. A escolha do esquema para o tratamento continuado do asmático e do portador de DPOC é especialmente
influenciada pela publicação de resultados de ensaios terapêuticos na literatura. Conclusões:A opinião do pneumo-logista sobre os temas abordados está de acordo com a literatura especializada.
Abstract
Objective:To evaluate how pulmonologists view the impact that asthma and COPD has on their patients, as well
as how they treat these diseases. Methods:Survey including 227 pulmonologists participating in the VI Brazilian
Asthma Conference, II Brazilian COPD Conference and II Brazilian Smoking Conference, all of which were held in
2007. Results: According to the answers given by the pulmonologists, COPD is a public health problem of equal
or greater importance than asthma, and COPD causes various disruptions in the lives of patients and their family
members. When prescribing an inhalation device, pulmonologists feel that simplicity of use is more important
than is the cost. There was a slight preference for the Aeroliser
®
and Diskus
®
systems. The budesonide-formoterol
combination was the therapeutic regimen most often cited for the continued treatment of the symptomatic
asthma, whereas tiotropium bromide was the most often cited medication for the treatment of patients with COPD.
Selection of the therapeutic regimen for asthma and COPD is primarily influenced by the results of therapeutic
trials published in the literature. Conclusions:The opinions of pulmonologists on the topics under study are in
concordance with data in the specialized literature.
Keywords
QuestionnairesAsthma
Pulmonary Disease
Chronic Obstructive
Physician’s Practice Patterns
Brazil
Share